Factors affecting breast milk composition and potential consequences for development of the allergic phenotype

Clinical and Experimental Allergy

Volumn 45, Issue 3, 2015, Pages 583-601

  Munblit, D ^a,b   Boyle, R J ^a,b   Warner, J O ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Worldwide Universities Network   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPID; POLYUNSATURATED FATTY ACID; TOBACCO SMOKE;

ALLERGY; BREAST MILK; COLOSTRUM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FOOD ALLERGY; FOOD COMPOSITION; HABITAT; HUMAN; IMMUNE RESPONSE; INFANT FEEDING; INTESTINE LYMPHATIC TISSUE; MATERNAL NUTRITION; MICROBIOME; MILK; MOLECULE; PHENOTYPE; PHYSICAL ACTIVITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SYSTEMATIC REVIEW (TOPIC); BREAST FEEDING; CHEMISTRY; ENVIRONMENT; HYPERSENSITIVITY; IMMUNITY; IMMUNOLOGY; INFANT; MICROBIOLOGY; NEWBORN; RISK;

BREAST FEEDING; COLOSTRUM; ENVIRONMENT; HUMANS; HYPERSENSITIVITY; IMMUNITY; INFANT; INFANT, NEWBORN; MILK, HUMAN; PHENOTYPE; RISK;

EID: 84923477289     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12381     Document Type: Review

References (158)

1. Williams H, Robertson C, Stewart A et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103(1 Pt 1):125-38.
2. Garofalo R. Cytokines in human milk. J Pediatr 2010; 156(Suppl. 2):S36-40.
3. Imhoff B, Morse D, Shiferaw B et al. Burden of self-reported acute diarrheal illness in FoodNet surveillance areas, 1998-1999. Clin Infect Dis 2004; 38(Suppl. 3):S219-26.
4. Kuehni CE, Strippoli MP, Low N, Silverman M. Asthma in young south Asian women living in the United Kingdom: the importance of early life. Clin Exp Allergy 2007; 37:47-53.
5. Ramsay AJ, Leong KH, Boyle D, Ruby J, Ramshaw IA. Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod Fertil Dev 1994; 6:389-92.
6. Munblit D, Boyle RJ. Modulating breast milk composition - the key to allergy prevention? Int Arch Allergy Immunol 2012; 159:107-8.
7. Borsutzky S, Cazac BB, Roes J, Guzman CA. TGF-beta receptor signaling is critical for mucosal IgA responses. J Immunol 2004; 173:3305-9.
8. Jones CA, Holloway JA, Popplewell EJ et al. Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 2002; 109:858-66.
9. Orlando S. The immunologic significance of breast milk. J Obstet Gynecol Neonatal Nurs 1995; 24:678-83.
10. Billington WD. The normal fetomaternal immune relationship. Baillieres Clin Obstet Gynaecol 1992; 6:417-38.
11. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005; 135:1304-7.
12. Newburg DS, Ruiz-Palacios GM, Altaye M et al. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 2004; 14:253-63.
13. Morrow AL, Ruiz-Palacios GM, Altaye M et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr 2004; 145:297-303.
14. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev 2012; 8:CD003517.
15. Bachrach VR, Schwarz E, Bachrach LR. Breastfeeding and the risk of hospitalization for respiratory disease in infancy: a meta-analysis. Arch Pediatr Adolesc Med 2003; 157:237-43.
16. Grulee C, Sanford H. The influence of breast and artificial feeding on infantile eczema. J Pediatr 1936; 9:223-5.
17. Gruber C, van Stuijvenberg M, Mosca F et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010; 126:791-7.
18. WHO. Global strategy for infant and young child feeding, the optimal duration of exclusive breastfeeding. Geneva: World Health Organization, 2001.
19. WHO. WHO global data bank on infant and young child feeding. Geneva: World Health Organization, 2009.
20. WHO. Infant and young child feeding. Geneva: World Health Organization, 2009.
21. Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma in childhood: a systematic review with meta-analysis of prospective studies. J Pediatr 2001; 139:261-6.
22. Gdalevich M, Mimouni D, David M, Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001; 45:520-7.
23. van Odijk J, Kull I, Borres MP et al. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy 2003; 58:833-43.
24. Laubereau B, Brockow I, Zirngibl A et al. Effect of breast-feeding on the development of atopic dermatitis during the first 3 years of life-results from the GINI-birth cohort study. J Pediatr 2004; 144:602-7.
25. Giwercman C, Halkjaer LB, Jensen SM, Bonnelykke K, Lauritzen L, Bisgaard H. Increased risk of eczema but reduced risk of early wheezy disorder from exclusive breast-feeding in high-risk infants. J Allergy Clin Immunol 2010; 125:866-71.
26. Elliott L, Henderson J, Northstone K, Chiu GY, Dunson D, London SJ. Prospective study of breast-feeding in relation to wheeze, atopy, and bronchial hyperresponsiveness in the Avon Longitudinal Study of Parents and Children (ALSPAC). J Allergy Clin Immunol 2008; 122:49-54e1-3.
27. Kramer MS, Chalmers B, Hodnett ED et al. Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA 2001; 285:413-20.
28. Kneepkens CM, Brand PL. Clinical practice: breastfeeding and the prevention of allergy. Eur J Pediatr 2010; 169:911-17.
29. Hong X, Wang G, Liu X et al. Gene polymorphisms, breast-feeding, and development of food sensitization in early childhood. J Allergy Clin Immunol 2011; 128:374-81 e2.
30. Tomicic S, Johansson G, Voor T, Bjorksten B, Bottcher MF, Jenmalm MC. Breast milk cytokine and IgA composition differ in Estonian and Swedish mothers-relationship to microbial pressure and infant allergy. Pediatr Res 2010; 68:330-4.
31. Amoudruz P, Holmlund U, Schollin J, Sverremark-Ekstrom E, Montgomery SM. Maternal country of birth and previous pregnancies are associated with breast milk characteristics. Pediatr Allergy Immunol 2009; 20:19-29.
32. Plagemann A, Harder T, Franke K, Kohlhoff R. Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care 2002; 25:16-22.
33. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9:88.
34. Lessard A, Turcotte H, Cormier Y, Boulet LP. Obesity and asthma: a specific phenotype? Chest 2008; 134:317-23.
35. D'Alessandro A, Scaloni A, Zolla L. Human milk proteins: an interactomics and updated functional overview. J Proteome Res 2010; 9:3339-73.
36. von Berg A, Filipiak-Pittroff B, Kramer U et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008; 121:1442-7.
37. Foisy M, Boyle RJ, Chalmers JR, Simpson EL, Williams HC. Overview of reviews the prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid Based Child Health 2011; 6:1322-39.
38. Piemontese P, Gianni ML, Braegger CP et al. Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial. PLoS ONE 2011; 6:e28010.
39. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006; 91:814-19.
40. Kramer MS. Does breast feeding help protect against atopic disease? Biology, methodology, and a golden jubilee of controversy. J Pediatr 1988; 112:181-90.
41. Matheson MC, Allen KJ, Tang ML. Understanding the evidence for and against the role of breastfeeding in allergy prevention. Clin Exp Allergy 2012; 42:827-51.
42. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991; 173:25-36.
43. Playford RJ, Macdonald CE, Johnson WS. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 2000; 72:5-14.
44. Lawrence RM, Pane CA. Human breast milk: current concepts of immunology and infectious diseases. Curr Probl Pediatr Adolesc Health Care 2007; 37:7-36.
45. Garofalo R, Chheda S, Mei F et al. Interleukin-10 in human milk. Pediatr Res 1995; 37(4 Pt 1):444-9.
46. Lonnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003; 77:1537S-43S.
47. Chowanadisai W, Lonnerdal B. Alpha(1)-antitrypsin and antichymotrypsin in human milk: origin, concentrations, and stability. Am J Clin Nutr 2002; 76:828-33.
48. Garofalo RP, Goldman AS. Cytokines, chemokines, and colony-stimulating factors in human milk: the 1997 update. Biol Neonate 1998; 74:134-42.
49. Kobata R, Tsukahara H, Ohshima Y et al. High levels of growth factors in human breast milk. Early Human Dev 2008; 84:67-9.
50. Prokesova L, Lodinova-Zadnikova R, Zizka J et al. Cytokine levels in healthy and allergic mothers and their children during the first year of life. Pediatr Allergy Immunol 2006; 17:175-83.
51. van Vlasselaer P, Punnonen J, de Vries JE. Transforming growth factor-beta directs IgA switching in human B cells. J Immunol 1992; 148:2062-7.
52. Kalliomaki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E. Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. J Allergy Clin Immunol 1999; 104:1251-7.
53. Ogawa J, Sasahara A, Yoshida T et al. Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants. Early Human Dev 2004; 77:67-75.
54. Strobel S. Oral tolerance, systemic immunoregulation, and autoimmunity. Ann N Y Acad Sci 2002; 958:47-58.
55. Landmann R, Muller B, Zimmerli W. CD14, new aspects of ligand and signal diversity. Microbes Infect 2000; 2:295-304.
56. Kielian TL, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 1995; 29:187-205.
57. Maliszewski CR. CD14 and immune response to lipopolysaccharide. Science 1991; 252:1321-2.
58. Fernandez L, Langa S, Martin V et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res 2013; 69:1-10.
59. Martin HM, Hancock JT, Salisbury V, Harrison R. Role of xanthine oxidoreductase as an antimicrobial agent. Infect Immun 2004; 72:4933-9.
60. Oshida K, Shimizu T, Takase M, Tamura Y, Yamashiro Y. Effects of dietary sphingomyelin on central nervous system myelination in developing rats. Pediatr Res 2003; 53:589-93.
61. Kivinen A, Tarpila S, Kiviluoto T, Mustonen H, Kivilaakso E. Milk and egg phospholipids act as protective surfactants against luminal acid in Necturus gastric mucosa. Aliment Pharmacol Ther 1995; 9:685-91.
62. Anand BS, Romero JJ, Sanduja SK, Lichtenberger LM. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol 1999; 94:1818-22.
63. Carlson SE, Montalto MB, Ponder DL, Werkman SH, Korones SB. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr Res 1998; 44:491-8.
64. Skokos D, Botros HG, Demeure C et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 2003; 170:3037-45.
65. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 2007; 1:156-8.
66. Admyre C, Bohle B, Johansson SM et al. B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J Allergy Clin Immunol 2007; 120:1418-24.
67. Admyre C, Johansson SM, Qazi KR et al. Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007; 179:1969-78.
68. Bottcher MF, Jenmalm MC, Bjorksten B. Cytokine, chemokine and secretory IgA levels in human milk in relation to atopic disease and IgA production in infants. Pediatr Allergy Immunol 2003; 14:35-41.
69. Striker GA, Casanova LD, Nagao AT. Influence of type of delivery on A, G and M immunoglobulin concentration in maternal colostrum. Jornal de pediatria 2004; 80:123-8. Influencia do tipo de parto sobre a concentracao de imunoglobulinas A, G e M no colostro materno.
70. Bachour P, Yafawi R, Jaber F, Choueiri E, Abdel-Razzak Z. Effects of smoking, mother's age, body mass index, and parity number on lipid, protein, and secretory immunoglobulin A concentrations of human milk. Breastfeed Med 2012; 7:179-88.
71. Hurley WL, Theil PK. Perspectives on immunoglobulins in colostrum and milk. Nutrients 2011; 3:442-74.
72. Savilahti E, Siltanen M, Kajosaari M, Vaarala O, Saarinen KM. IgA antibodies, TGF-beta1 and -beta2, and soluble CD14 in the colostrum and development of atopy by age 4. Pediatr Res 2005; 58:1300-5.
73. Kuitunen M, Kukkonen AK, Savilahti E. Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int Arch Allergy Immunol 2012; 159:162-70.
74. Orivuori L, Loss G, Roduit C et al. Soluble immunoglobulin A in breast milk is inversely associated with atopic dermatitis at early age: the PASTURE cohort study. Clin Exp Allergy 2014; 44:102-12.
75. Bottcher MF, Abrahamsson TR, Fredriksson M, Jakobsson T, Bjorksten B. Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 2008; 19:497-504.
76. Saarinen KM, Vaarala O, Klemetti P, Savilahti E. Transforming growth factor-beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. J Allergy Clin Immunol 1999; 104:1093-8.
77. Boyle RJ, Ismail IH, Kivivuori S et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011; 66:509-16.
78. Ustundag B, Yilmaz E, Dogan Y et al. Levels of cytokines (IL-1beta, IL-2, IL-6, IL-8, TNF-alpha) and trace elements (Zn, Cu) in breast milk from mothers of preterm and term infants. Mediators Inflamm 2005; 2005:331-6.
79. Bryan DL, Forsyth KD, Gibson RA, Hawkes JS. Interleukin-2 in human milk: a potential modulator of lymphocyte development in the breastfed infant. Cytokine 2006; 33:289-93.
80. Bottcher MF, Jenmalm MC, Garofalo RP, Bjorksten B. Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res 2000; 47:157-62.
81. Marek A, Zagierski M, Liberek A et al. TGF-beta(1), IL-10 and IL-4 in colostrum of allergic and nonallergic mothers. Acta Biochim Pol 2009; 56:411-14.
82. Rudloff S, Niehues T, Rutsch M, Kunz C, Schroten H. Inflammation markers and cytokines in breast milk of atopic and nonatopic women. Allergy 1999; 54:206-11.
83. Snijders BE, Damoiseaux JG, Penders J et al. Cytokines and soluble CD14 in breast milk in relation with atopic manifestations in mother and infant (KOALA Study). Clin Exp Allergy 2006; 36:1609-15.
84. Smith CW, Goldman AS. The cells of human colostrum. I. In vitro studies of morphology and functions. Pediatr Res 1968; 2:103-9.
85. Marzi M, Vigano A, Trabattoni D et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-33.
86. Bryan DL, Hawkes JS, Gibson RA. Interleukin-12 in human milk. Pediatr Res 1999; 45:858-9.
87. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
88. McKenzie AN, Culpepper JA, de Waal Malefyt R et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90:3735-9.
89. Wynn TA. IL-13 effector functions. Annu Rev Immunol 2003; 21:425-56.
90. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001; 97:14-32.
91. Mastroianni CM, D'Ettorre G, Forcina G, Vullo V. Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy? Trends Immunol 2004; 25:121-5.
92. Walter J, Ghosh MK, Kuhn L et al. High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J Infect Dis 2009; 200:1498-502.
93. Bocci V, von Bremen K, Corradeschi F, Franchi F, Luzzi E, Paulesu L. Presence of interferon-gamma and interleukin-6 in colostrum of normal women. Lymphokine Cytokine Res 1993; 12:21-4.
94. Eglinton BA, Roberton DM, Cummins AG. Phenotype of T cells, their soluble receptor levels, and cytokine profile of human breast milk. Immunol Cell Biol 1994; 72:306-13.
95. Cerutti A, Zan H, Schaffer A et al. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 1998; 160:2145-57.
96. Oddy WH, Rosales F. A systematic review of the importance of milk TGF-beta on immunological outcomes in the infant and young child. Pediatr Allergy Immunol 2010; 21(1 Pt 1):47-59.
97. Ando T, Hatsushika K, Wako M et al. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J Allergy Clin Immunol 2007; 120:916-23.
98. Nakao A. The role and potential use of oral transforming growth factor-beta in the prevention of infant allergy. Clin Exp Allergy 2010; 40:725-30.
99. Filipp D, Alizadeh-Khiavi K, Richardson C et al. Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proc Natl Acad Sci USA 2001; 98:603-8.
100. Wang Z, Sundy JS, Foss CM et al. Racial differences in the association of CD14 polymorphisms with serum total IgE levels and allergen skin test reactivity. J Asthma Allergy 2013; 6:81-92.
101. Ismail IH, Licciardi PV, Oppedisano F, Boyle RJ, Tang ML. Relationship between breast milk sCD14, TGF-beta1 and total IgA in the first month and development of eczema during infancy. Pediatr Allergy Immunol 2013; 24:352-60.
102. Lee SY, Kang MJ, Kwon JW, Park KS, Hong SJ. Breastfeeding might have protective effects on atopy in children with the CD14C-159T CT/CC genotype. Allergy Asthma Immunol Res 2013; 5:239-41.
103. Thurl S, Henker J, Siegel M, Tovar K, Sawatzki G. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconj J 1997; 14:795-9.
104. Coppa GV, Gabrielli O, Pierani P, Catassi C, Carlucci A, Giorgi PL. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics 1993; 91:637-41.
105. Donovan SM. Human milk oligosaccharides - the plot thickens. Br J Nutr 2009; 101:1267-9.
106. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 2009; 67(Suppl. 2):S183-91.
107. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol 2006; 72:4497-9.
108. Newburg DS. Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria? J Nutr 1997; 127(Suppl. 5):980S-4S.
109. Newburg DS. Human milk glycoconjugates that inhibit pathogens. Curr Med Chem 1999; 6:117-27.
110. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 2001; 73(Suppl. 2):399S-405S.
111. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001; 108:144-5.
112. Prescott SL, Dunstan JA. Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids 2007; 42:801-10.
113. Reichardt P, Muller D, Posselt U et al. Fatty acids in colostrum from mothers of children at high risk of atopy in relation to clinical and laboratory signs of allergy in the first year of life. Allergy 2004; 59:394-400.
114. Duchen K, Casas R, Fageras-Bottcher M, Yu G, Bjorksten B. Human milk polyunsaturated long-chain fatty acids and secretory immunoglobulin A antibodies and early childhood allergy. Pediatr Allergy Immunol 2000; 11:29-39.
115. Kankaanpaa P, Nurmela K, Erkkila A et al. Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy 2001; 56:633-8.
116. Stoney RM, Woods RK, Hosking CS, Hill DJ, Abramson MJ, Thien FC. Maternal breast milk long-chain n-3 fatty acids are associated with increased risk of atopy in breastfed infants. Clin Exp Allergy 2004; 34:194-200.
117. Enke U, Seyfarth L, Schleussner E, Markert UR. Impact of PUFA on early immune and fetal development. The British Journal of Nutrition 2008; 100:1158-68.
118. de Roos B, McArdle HJ. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. The British Journal of Nutrition 2008; 99(Suppl. 3):S66-71.
119. de Roos B. Proteomic analysis of human plasma and blood cells in nutritional studies: development of biomarkers to aid disease prevention. Expert Rev Proteomics 2008; 5:819-26.
120. Zanardo V, Nicolussi S, Cavallin S et al. Effect of maternal smoking on breast milk interleukin-1alpha, beta-endorphin, and leptin concentrations and leptin concentrations. Environ Health Perspect 2005; 113:1410-13.
121. Agostoni C, Marangoni F, Grandi F et al. Earlier smoking habits are associated with higher serum lipids and lower milk fat and polyunsaturated fatty acid content in the first 6 months of lactation. Eur J Clin Nutr 2003; 57:1466-72.
122. Castellote C, Casillas R, Ramirez-Santana C et al. Premature delivery influences the immunological composition of colostrum and transitional and mature human milk. J Nutr 2011; 141:1181-7.
123. Groer MW, Shelton MM. Exercise is associated with elevated proinflammatory cytokines in human milk. J Obstet Gynecol Neonatal Nurs 2009; 38:35-41.
124. Hoppu U, Isolauri E, Laakso P, Matomaki J, Laitinen K. Probiotics and dietary counselling targeting maternal dietary fat intake modifies breast milk fatty acids and cytokines. Eur J Nutr 2012; 51:211-19.
125. Laiho K, Lampi AM, Hamalainen M et al. Breast milk fatty acids, eicosanoids, and cytokines in mothers with and without allergic disease. Pediatr Res 2003; 53:642-7.
126. Lauritzen L, Halkjaer LB, Mikkelsen TB et al. Fatty acid composition of human milk in atopic Danish mothers. Am J Clin Nutr 2006; 84:190-6.
127. Urwin HJ, Miles EA, Noakes PS et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. J Nutr 2012; 142:1603-10.
128. Dunstan JA, Mori TA, Barden A et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 2003; 112:1178-84.
129. Johansson S, Wold AE, Sandberg AS. Low breast milk levels of long-chain n-3 fatty acids in allergic women, despite frequent fish intake. Clin Exp Allergy 2011; 41:505-15.
130. Ameur A, Enroth S, Johansson A et al. Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am J Hum Genet 2012; 90:809-20.
131. Prescott SL, Wickens K, Westcott L et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy 2008; 38:1606-14.
132. Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163:616-23.
133. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130:1355-60.
134. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev 2012; 9:CD000133.
135. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259-60.
136. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000; 55(Suppl. 1):S2-10.
137. Peroni DG, Pescollderungg L, Piacentini GL et al. Immune regulatory cytokines in the milk of lactating women from farming and urban environments. Pediatr Allergy Immunol 2010; 21:977-82.
138. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr 2010; 156(Suppl. 2):S8-15.
139. Mimouni Bloch A, Mimouni D, Mimouni M, Gdalevich M. Does breastfeeding protect against allergic rhinitis during childhood? A meta-analysis of prospective studies Acta Paediatr 2002; 91:275-9.
140. Ip S, Chung M, Raman G et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report/Technology Assessment 2007; 153:1-186.
141. Yang YW, Tsai CL, Lu CY. Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol 2009; 161:373-83.
142. Dogaru CM, Nyffenegger D, Pescatore AM, Spycher BD, Kuehni CE. Breastfeeding and childhood asthma: systematic review and meta-analysis. Am J Epidemiol 2014; 179:1153-67.
143. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 2012; 96:544-51.
144. Gueimonde M, Laitinen K, Salminen S, Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 2007; 92:64-6.
145. Hunt KM, Foster JA, Forney LJ et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS ONE 2011; 6:e21313.
146. Islam SK, Ahmed L, Khan MN, Huque S, Begum A, Yunus AB. Immune components (IgA, IgM, IgG, immune cells) of colostrum of Bangladeshi mothers. Pediatr Int 2006; 48:543-8.
147. Bryan DL, Hart PH, Forsyth KD, Gibson RA. Immunomodulatory constituents of human milk change in response to infant bronchiolitis. Pediatr Allergy Immunol 2007; 18:495-502.
148. Oddy WH, Halonen M, Martinez FD et al. TGF-beta in human milk is associated with wheeze in infancy. J Allergy Clin Immunol 2003; 112:723-8.
149. Rigotti E, Piacentini GL, Ress M, Pigozzi R, Boner AL, Peroni DG. Transforming growth factor-beta and interleukin-10 in breast milk and development of atopic diseases in infants. Clin Exp Allergy 2006; 36:614-18.
150. Rudloff HE, Schmalstieg FC Jr, Mushtaha AA, Palkowetz KH, Liu SK, Goldman AS. Tumor necrosis factor-alpha in human milk. Pediatr Res 1992; 31:29-33.
151. Kverka M, Burianova J, Lodinova-Zadnikova R et al. Cytokine profiling in human colostrum and milk by protein array. Clin Chem 2007; 53:955-62.
152. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109:119-21.
153. Holmlund U, Amoudruz P, Johansson MA et al. Maternal country of origin, breast milk characteristics and potential influences on immunity in offspring. Clin Exp Immunol 2010; 162:500-9.
154. Yamada Y, Saito S, Morikawa H. Hepatocyte growth factor in human breast milk. Am J Reprod Immunol 1998; 40:112-20.
155. Lowe AJ, Thien FC, Stoney RM et al. Associations between fatty acids in colostrum and breast milk and risk of allergic disease. Clin Exp Allergy 2008; 38:1745-51.
156. Thijs C, Muller A, Rist L et al. Fatty acids in breast milk and development of atopic eczema and allergic sensitisation in infancy. Allergy 2011; 66:58-67.
157. Higashi T, Shimojo N, Suzuki S et al. Coenzyme A contained in mothers' milk is associated with the potential to induce atopic dermatitis. Int Immunol 2011; 23:741-9.
158. Sidor K, Jarmolowska B, Kaczmarski M, Kostyra E, Iwan M, Kostyra H. Content of beta-casomorphins in milk of women with a history of allergy. Pediatr Allergy Immunol 2008; 19:587-91.